Chemoprevention in Bladder Cancer: What's New?
Overview
Authors
Affiliations
Bladder cancer is the sixth most common tumour in Canada and ranks eighth in terms of cancer mortality. Up to now, management of this condition relied mostly on surgical and intravesical treatments once the disease is established. Chemoprevention is an attractive option to prevent the disease in high-risk populations and may well reduce the costs related to its treatment. This review examines the available data on chemoprevention strategies in bladder cancer, with special emphasis on randomized controlled trials when available.
Sulforaphane for the chemoprevention of bladder cancer: molecular mechanism targeted approach.
Leone A, Diorio G, Sexton W, Schell M, Alexandrow M, Fahey J Oncotarget. 2017; 8(21):35412-35424.
PMID: 28423681 PMC: 5471065. DOI: 10.18632/oncotarget.16015.
Omega-3 fatty acids inhibit tumor growth in a rat model of bladder cancer.
Parada B, Reis F, Cerejo R, Garrido P, Sereno J, Xavier-Cunha M Biomed Res Int. 2013; 2013:368178.
PMID: 23865049 PMC: 3705844. DOI: 10.1155/2013/368178.
Role of oxidative stress in cytotoxicity of grape seed extract in human bladder cancer cells.
Raina K, Tyagi A, Kumar D, Agarwal R, Agarwal C Food Chem Toxicol. 2013; 61:187-95.
PMID: 23831192 PMC: 3851932. DOI: 10.1016/j.fct.2013.06.039.
Tea consumption and risk of bladder cancer: a meta-analysis.
Qin J, Xie B, Mao Q, Kong D, Lin Y, Zheng X World J Surg Oncol. 2012; 10:172.
PMID: 22920932 PMC: 3499443. DOI: 10.1186/1477-7819-10-172.